- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
109
10 new
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
109 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHM | €74.55 | -5.5% | 97.4% | €1.3b | €84.60 | PE2102.1x | E56.4% | 0.9% | ||
A064550 | ₩19,720.00 | -1.2% | -36.3% | ₩515.9b | n/a | PS1.7x | E97.6% | n/a | ||
A039200 | ₩24,450.00 | 3.6% | 26.2% | ₩943.6b | ₩56,000.00 | PS29.4x | E132.4% | n/a | ||
MEDCL | €17.20 | -3.9% | 179.2% | €500.3m | €22.45 | PS41.9x | E92.2% | n/a | ||
ACR | AU$0.046 | 2.2% | 7.0% | AU$13.1m | AU$0.19 | PS2.6x | E91.6% | 0% | ||
A196170 | ₩347,500.00 | -21.3% | 375.4% | ₩18.7t | ₩390,000.00 | PS204x | E94.1% | n/a | ||
BIOA B | SEK 178.10 | 17.6% | -24.5% | SEK 15.7b | SEK 320.80 | PS94.3x | E62.2% | 0% | ||
EGTX | SEK 5.43 | 4.8% | 2.5% | SEK 2.0b | SEK 10.80 | PS28.7x | E106.4% | n/a | ||
688076 | CN¥54.77 | -0.9% | 22.4% | CN¥11.9b | CN¥85.00 | PE28.6x | E31.4% | 0.4% | ||
9926 | HK$73.25 | 7.6% | 54.4% | HK$63.1b | HK$72.16 | PS32.6x | E53.3% | n/a | ||
BIOVIC B | SEK 1.80 | 3.3% | -35.6% | SEK 162.8m | SEK 6.20 | PS22.5x | E78.5% | n/a | ||
CTX | zł51.60 | -12.5% | -42.7% | zł240.6m | zł121.13 | PS12.4x | E71.9% | n/a | ||
CLNN New | US$4.09 | -15.1% | -56.9% | US$37.2m | US$46.17 | PS77.5x | E60.7% | n/a | ||
A216080 | ₩17,920.00 | 3.4% | 5.2% | ₩320.3b | ₩28,000.00 | PE15.8x | E35.3% | n/a | ||
300573 | CN¥84.84 | -6.5% | -21.9% | CN¥15.0b | n/a | PE42.7x | E32.8% | 2.4% | ||
TLX | AU$22.20 | -3.1% | 141.8% | AU$7.7b | AU$25.62 | PE151.1x | E38.3% | n/a | ||
688621 | CN¥42.74 | -4.8% | -36.1% | CN¥4.9b | n/a | PE21.6x | E29.5% | 0.4% | ||
ADOC | €8.33 | 4.5% | -1.2% | €126.9m | €6.30 | PS35.3x | E64.0% | n/a | ||
CORT | US$56.09 | -0.6% | 121.3% | US$5.7b | US$74.90 | PE41.8x | E41.0% | n/a | ||
CUV | AU$13.16 | -2.7% | -22.0% | AU$669.3m | AU$28.29 | PE18.4x | E26.2% | 0.4% | ||
VEXT | CA$0.20 | 5.4% | -39.1% | CA$45.8m | CA$0.67 | PS1x | E111.1% | n/a | ||
SPRY New | US$13.55 | -3.8% | 186.5% | US$1.3b | US$26.50 | PS512.8x | E69.8% | n/a | ||
AETHER | ₹830.35 | 1.6% | -6.9% | ₹109.8b | ₹1,097.00 | PE136.3x | E44.8% | n/a | ||
300181 | CN¥17.42 | 3.9% | 61.7% | CN¥11.7b | CN¥21.00 | PE23.1x | E23.3% | 2.6% |